Cinfa Banks On ‘Multi-Layered’ Scientific Advice As It Files For EU Pegfilgrastim Biosimilar Review

 
• By Neena Brizmohun

Cinfa Biotech is hoping that the advice it received from the EU regulators during the development of its pegfilgrastim biosimilar will help it succeed where others have failed.

sales manager giving advice to his couple clients
Cinfa Biotech sought extensive scientific advice for its biosimilar • Source: Shutterstock

More from Biosimilars

More from Biosimilars & Generics